The molecular mechanisms that regulate integrin-ligand binding are unknown ; however, bivalent cations are essential for integrin activity. According to recent models of integrin tertiary structure, sites involved in ligand recognition are located on the upper face of the seven-bladed β-propeller formed by the N-terminal repeats of the α subunit and on the von Willebrand factor A-domain-like region of the β subunit. The epitopes of function-altering monoclonal antibodies (mAbs) cluster in these regions of the α and β subunits ; hence these mAbs can be used as probes to detect changes in the exposure or shape of the ligand-binding sites. Bivalent cations were found to alter the apparent affinity of binding of the inhibitory anti-α5 mAbs JBS5 and 16, the inhibitory anti-β1 mAb 13, and the stimulatory anti-β1 mAb
INTRODUCTION
Cells make adhesive contacts with their environment through cell-surface receptors, many of which belong to the integrin gene superfamily. Integrins are heterodimers containing α and β subunits ; receptors containing the β1 subunit constitute the principal group of cell-matrix receptors. A striking feature of integrin-ligand interactions is that they can be dynamically regulated : integrins can exist in inactive or active states, with only the active state competent to bind ligand. Acquisition of the active state requires bivalent cations and is accompanied by conformational changes, involving both α and β subunits [1] .
The N-terminal portion of integrin α subunits comprises seven homologous, tandemly repeated domains of about 60 amino acids each. Repeats 4-7 (or in some integrins 5-7) each contain cation-binding sequences, similar to the EF-hand motif found in Ca# + -binding proteins such as calmodulin [2] . Recently, the Nterminal repeats have been proposed to form a seven-bladed β-propeller structure in which a bivalent ion is co-ordinated at the centre of the propeller [3] . An additional cation-binding site is found in a highly conserved region close to the N-terminus of the β subunit [4, 5] . This region is predicted to have a von Willebrand factor A domain-like fold [6] [7] [8] [9] .
Sites involved in ligand binding have been identified in the Nterminal regions of both α and β subunits. The N-terminal repeats of the α subunit and the putative A-domain region of the β subunit appear to contain sequences that participate directly in ligand recognition (for a review see [10] ). The epitopes of monoclonal antibodies (mAbs) that inhibit β1 integrin function have been mapped to a region containing amino acid residues 207-218 within the putative A-domain ; intriguingly, this region also includes the epitopes of several mAbs that stimulate integrin Abbreviation used : mAb, monoclonal antibody. 1 To whom correspondence should be addressed (e-mail : pmould!fs1.scg.man.ac.uk). 2 Present address : Max-Delbruek-Centrum, Robert-Roessle-Strasse 10, 13122 Berlin, Germany.
12G10 to α5β1. Analysis of the binding of these mAbs to α5β1 over a range of Mn# + , Mg# + or Ca# + concentrations demonstrated that there was a concordance between the ability of cations to elicit conformational changes and the ligand-binding potential of α5β1. Competitive ELISA experiments provided evidence that the domains of the α5 and β1 subunits recognized by mAbs JBS5\16 and 13\12G10 are spatially close, and that the distance between these two domains is increased when α5β1 is occupied by bivalent cations. Taken together, our findings suggest that bivalent cations induce a conformational relaxation in the integrin that results in exposure of ligand-binding sites, and that these sites lie near an interface between the α subunit β-propeller and the β subunit putative A-domain.
function [11] . The epitopes of inhibitory mAbs that recognize the α4 or α5 subunits cluster in the second and third of the Nterminal repeats [12] [13] [14] [15] , and involve putative loop regions on the upper surface of the α subunit β-propeller [15] [16] [17] . We have shown that the epitopes of inhibitory anti-α5 and anti-β1 mAbs are close to, but not directly overlapping with, sites involved in ligand binding [15, 18] . These mAbs do not act as ligand mimetics ; however, because of the close proximity of their epitopes to ligand-binding sites, these mAbs can be used as probes to detect changes in the exposure or conformation of the ligand-binding domains.
Although it is clear that bivalent-cation occupancy and ligand binding are intimately linked, the precise role of bivalent cations in integrin-ligand interactions remains uncertain. In a recent study, we found that Mn# + , Mg# + and Ca# + have markedly different effects on ligand recognition by α5β1 [19] . Both Mn# + and Mg# + supported ligand binding, but Mn# + supported higheraffinity ligand binding than Mg# + ; in contrast, Ca# + supported ligand binding very poorly, and was a non-competitive inhibitor of ligand binding supported by Mn# + . Our studies also indicated that several distinct cation-binding sites are involved in regulating the ligand-binding activity of α5β1.
Here we have investigated the effect of Mn# + , Mg# + and Ca# + on the binding of inhibitory mAbs to α5β1. We also compare the effect of these ions on the binding of the activating mAb 12G10 [20] , which recognizes the same region of the β1 subunit as inhibitory anti-β1 mAbs. We show that cation-induced conformational changes reported by changes in the binding of these function-perturbing mAbs to α5β1 correlate with the effects of cations on the ligand-binding activity of α5β1. Competitive ELISA experiments provide evidence that the epitopes of some function-altering anti-α5 and anti-β1 mAbs are spatially close.
Our data suggest a mechanism by which conformational changes lead to the exposure of ligand-binding sites within α5β1 ; this mechanism is consistent with recently proposed models of integrin activation [21, 22] .
MATERIALS AND METHODS

Materials
Rat mAbs 16 and 11 recognizing the human α5 subunit, and mAb 13 recognizing the human β1 integrin, were gifts from Dr. S. K. Akiyama (National Institute of Environmental Health Sciences, NIH, Chapel Hill, NC, U.S.A.). Mouse anti-human α5 mAbs P1D6 and JBS5 were purchased from Gibco-BRL and Serotec (Oxford, U.K.) respectively. Mouse anti-human β1 mAbs 4B4 and K20 were purchased from Coulter (Miami, FL, U.S.A.), and The Binding Site (Birmingham, U.K.) respectively. Mouse anti-human β1 integrin mAbs TS2\16 and SG\19 were gifts from F. Sa! nchez-Madrid (Hospital de la Princesa, Madrid, Spain) and K. Miyake (Saga Medical School, Saga, Japan) respectively. Mouse anti-human β1 integrin mAb 12G10 was produced and purified as described previously [20] . All antibodies were used as purified IgG, except P1D6 (as ascites). Integrin α5β1 was purified from human placenta as previously described [17] .
Biotinylation of mAbs
mAbs (0.5 mg\ml in PBS) were mixed with an equal mass of sulpho-N-hydroxysuccinimido biotin (Pierce) and rotary mixed for 30-40 min at room temperature. The mixture was then dialysed against several changes of 150 mM NaCl\25 mM Tris\HCl, pH 7.4, to remove excess biotin. The dialysate was centrifuged at 13 000 g for 15 min, and stored at k70 mC.
Effect of bivalent cations on the binding of mAbs to α5β1
Purified α5β1 integrin (at a concentration of $ 500 µg\ml) was diluted 1 : 500 with PBS containing bivalent cations, and 100 µl aliquots were added to the wells of a 96-well ELISA plate (Dynatech Immulon 3 or 4). Plates were incubated overnight at room temperature, and wells were blocked for 1-3 h with 200 µl of 5 % (w\v) BSA\150 mM NaCl\0.05 % (w\v) NaN $ \25 mM Tris\HCl, pH 7.4. Wells were then washed three times with 200 µl of 150 mM NaCl\25 mM Tris\HCl, pH 7.4, containing 1 mg\ml BSA (buffer A). Buffer A was treated with Chelex beads (Bio-Rad) to remove any small contaminating amounts of endogenous Ca# + and Mg# + ions. Aliquots (100 µl each) of biotinylated mAbs (0.03-10 µg\ml) in buffer A with 1 mM EDTA or 1 mM MnCl # were added to the wells. The plate was then incubated at 37 mC for 2 h. Unbound antibody was aspirated, and the wells were washed three times with buffer A. Bound antibody was quantified by addition of 1 : 500 dilution of ExtrAvidin peroxidase conjugate (Sigma) in buffer A for 20 min at room temperature. Wells were then washed four times with buffer A, and colour was developed using 2,2h-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) substrate. Measurements obtained were the meanspS.D. of four replicate wells. Apparent dissociation constants (K D ) were calculated using the equation To analyse the effect of a range of Mn# + , Mg# + and Ca# + concentrations on the binding of mAbs to α5β1, biotinylated mAbs were used at a constant concentration (0.1 µg\ml), and Mn# + , Mg# + or Ca# + was added to buffer A to a final concentration of 0.015-4 mM. To estimate the concentrations of bivalent cations required for half-maximal change in antibody binding (apparent K D values), non-linear regression analysis of the data was performed as described above.
Competitive ELISA experiments
ELISA plates were coated with α5β1, blocked and washed as described above. Biotinylated mAbs (0.1 µg\ml) in buffer A with 1 mM EDTA were added to the wells in the absence or presence of a large excess of unlabelled competitor mAbs (10 µg\ml or 1 : 500 dilution of ascites). The plate was then incubated at 37 mC for 2 h. Unbound antibodies were aspirated, and the wells washed three times with buffer A. Bound biotinylated antibody was detected as described above. Measurements obtained were the meanspS.D. of at least four replicate wells. Other modifications to this assay are described in the Figure legends .
In all the assays described above, the amount of non-specific binding was measured by determining the level of antibody binding to wells coated with BSA alone ; these values were subtracted from the corresponding values for receptor-coated wells. Each experiment shown is representative of at least three separate experiments. Under the conditions used in these assays, the ELISA signal appeared to be directly proportional to the amount of bound antibody because plots of 1\absorbance versus 1\[free antibody] did not deviate from linearity at high concentrations. Note, however, that binding constants cannot be precisely determined in these assays, and that only apparent K D values are quoted.
Mapping of the 12G10 epitope
Construction of mouse\human and chicken\human chimaeras and site-directed mutagenesis of the human β1 subunit were carried out as previously described [11] . Chimaeras and mutated human β1 were stably expressed on the surface of Chinese hamster ovary cells (as heterodimers with endogenous hamster α5), and the percentage of cells reactive to the mAbs was assessed by flow cytometry.
RESULTS
Bivalent cations modulate the apparent affinity of binding of function-altering mAbs to α5β1
We tested whether the binding of the anti-α5 mAbs JBS5, 16 and P1D6, and the anti-β1 mAbs 13, 4B4, TS2\16 and 12G10, to α5β1 was influenced by bivalent cations. These mAbs have been shown to have epitopes close to the ligand-binding domains of α5β1 and to alter integrin function (Table 1 ). In preliminary experiments (not shown), we found that Mn# + , Mg# + and Ca# + markedly changed the apparent affinity of mAbs JBS5, 16, 13 and 12G10 binding to α5β1. Significantly, Mn# + , a bivalent ion previously shown to be a potent stimulator of α5β1 function, caused the largest change in the binding of the mAbs to α5β1 (Figure 1 ). Whereas the apparent affinity of mAbs JBS5, 16 and 12G10 binding to α5β1 was increased by Mn# + , the apparent affinity of mAb 13 binding was decreased. The apparent affinity of P1D6, 4B4 and TS2\16 binding to α5β1 was altered 1.5-fold in the presence of cations (results not shown). The binding of the non-inhibitory mAbs 11 (against α5) and K20 (against β1) was also unaffected by Mn# + , Mg# + or Ca# + (results not shown).
Table 1 Specificity of the mAbs used in this study
Antibodies are categorized according to their function-altering activity (Inhib., inhibitory ; or Stim., stimulatory) ; mAbs 11 and K20 have no effect on integrin activity (n/l, neutral) and are used as controls. The epitopes of JBS5, 16 and P1D6 lie in the second and third repeats (R2/R3) of the α5 subunit ( [15] , and A. Irie and Y. Takada, unpublished work), whereas that of mAb 11 probably lies outside the N-terminal repeats (C-terminal) [15] . The epitopes of mAbs 13, 4B4 and TS2/16 include amino acid residues 207-218 in the putative A-domain of the β1 subunit [11] , whereas the epitope of K20 lies in amino acid residues 426-587 of β1 (outside the putative A-domain) [ 
Figure 1 Effect of bivalent cations on the binding of function-altering mAbs to α5β1
Binding of mAbs JBS5 (A), 16 (B), 13 (C) and 12G10 (D) was measured in the presence of 1 mM Mn 2 + ($) or in the presence of 1 mM EDTA (#). By non-linear regression analysis, the apparent affinities of binding of the mAbs to α5β1 are estimated to be as follows : JBS5, 18p1 nM ( 
The epitope of 12G10 is overlapping with those of other functionaltering anti-β1 mAbs
As described above, the epitopes of the function-altering mAbs used in this study have been localized to restricted regions of the α5 and β1 subunits. Competitive ELISA experiments had previously suggested that the epitope of 12G10 was very close to the region of the β1 subunit that contains the epitopes for inhibitory mAbs such as 13, and stimulatory mAbs such as TS2\16 [20] . To define further the part of the β1 subunit that contains the 12G10 epitope, we initially used mouse\human and chicken\human β1 chimaeras to localize the epitope to a specific region of β1. The results (Table 2) showed that the 12G10 epitope was included in a region containing amino acids 190-304. Since there are only five amino acid changes in this region from mouse to human β1 (and 12G10 does not react with mouse β1), point mutations in each of these five residues were made. The results (Table 3) showed that mutation of Lys218 abrogated 12G10 binding. Hence the epitope recognized by 12G10 probably includes this residue. Since amino acids 207-218 of β1 contain the epitopes of many function-altering anti-β1 mAbs [11] , the epitope of 12G10 appears to be overlapping with the epitopes of these mAbs.
Evidence that the epitopes of mAbs JBS5/16 and mAbs 13/12G10 are spatially close
There is evidence to suggest that the ligand-binding pocket on integrins is made up of elements from both α and β subunits that
Figure 4 Representation of overlap between the epitopes of functionaltering anti-α5 and anti-β1 mAbs
Epitopes of anti-α5 mAbs are shown white, epitopes of anti-β1 mAbs are shown hatched. Epitopes of mAbs that show altered binding when the integrin is occupied by bivalent cations are marked with an asterisk. The epitope of 4B4 is omitted for clarity, but is closely overlapping with those of mAbs 13 and 12G10. Note that while the Venn diagram cannot be used as a basis for estimating physical distances between clusters of epitopes, it can be used to exclude overlap and to give a qualitative approximation of proximity.
are brought into close proximity through the spatial folding of the polypeptide chains (for a review see [20] ). We therefore hypothesized that the epitopes of function-altering mAbs against the α5 subunit may be in spatial proximity to those of functionaltering mAbs against the β1 subunit, and hence binding of function-altering anti-β1 mAbs to α5β1 may sterically hinder the binding of function-altering anti-α5 mAbs and vice versa. To test this hypothesis, we used competitive ELISA experiments to determine whether anti-α5 mAbs and anti-β1 mAbs could compete with each other for binding to α5β1 (Figure 3) . Binding of biotinylated JBS5 to α5β1 was, as expected, blocked by unlabelled JBS5, and also by mAbs 16 and P1D6, whose epitopes lie in the same region of the α5 subunit. In addition, JBS5 binding was partially inhibited by the function-altering anti-β1 mAbs 13, 4B4 and 12G10 ( Figure 3A) . Interestingly, TS2\16 did not affect JBS5 binding, even though its epitope lies in the same region of the β1 subunit as those of 13, 4B4 and 12G10 [11] . Nonfunction-altering anti-α5 (mAb 11) and anti-β1 (K20) mAbs also did not inhibit JBS5 binding. Similar results were obtained for biotinylated mAb 16 ( Figure 3B ). In the converse experiments, binding of biotinylated mAb 13 to α5β1 was completely blocked by unlabelled mAb 13 and was also strongly inhibited by 4B4, 12G10 and TS2\16 ; mAbs that have epitopes in the same region of the β1 subunit ( [11] , and the present study). The binding of biotinylated mAb 13 was also partially inhibited by the anti-α5 mAbs JBS5 and 16, but not by P1D6 ( Figure 3C ). JBS5 and mAb 16 also partially inhibited biotinylated 12G10 binding to α5β1 ( Figure 3D ). In additional experiments, JBS5 and mAb 16 partially inhibited biotinylated 4B4 but not TS2\16 binding to α5β1 (results not shown). Based on the competitive ELISA results, a Venn diagram was constructed showing overlap between the epitopes of function-altering mAbs (Figure 4) . Importantly, this analysis suggests that the epitopes of the anti-α5 mAbs and anti-β1 mAbs that are spatially overlapping are mainly those that are affected by bivalent cations. These epitopes must lie close to the interface between α and β subunits.
The degree of cross competition between the binding of the function-altering anti-α5 and the anti-β1 mAbs to α5β1 was also influenced by bivalent cations. For each pair of anti-α5 and anti-β1 mAbs, there was less cross-competition between these mAbs in the presence of Mn# + than in the absence of cations ; an example is shown in Figure 5 . Mg# + or Ca# + also reduced the extent of cross-competition (results not shown). Taken together, the results indicate that the regions of the α5 and β1 subunits that contain the epitopes of JBS5\mAb 16 and mAb 13\12G10 are in spatial proximity to each other, but these two regions move further apart when the integrin is occupied by bivalent ions.
DISCUSSION
The novel findings of this report are the following. (i) Binding of the function-altering mAbs JBS5, 16, 13 and 12G10 to α5β1 is affected by occupancy of cation-binding sites on α5β1 ; some of these sites are of similar affinity to those identified from their effects on ligand recognition [19] . (ii) The effect of Mn# + , Mg# + and Ca# + on the binding of these mAbs can be correlated with the effects of each bivalent ion on the ligand-binding capacity of α5β1. (iii) Competitive ELISA experiments suggest that the regions of the α5 and β1 subunits recognized by JBS5\mAb 16 and mAb 13\12G10 (i.e. the second and third repeats of the α5 subunit β-propeller and amino acids 207-218 in the β1 subunit putative A-domain) are spatially close, and that these regions move further apart when the integrin is occupied by bivalent cations. Taken together, our data indicate that cation occupancy leads to a conformational change in the integrin that unmasks sites involved in ligand recognition, and that these sites lie near the interface between α and β subunits.
Our results suggest an explanation for the differences in the affinity of ligand binding by α5β1 in Mn# + as compared with Mg# + or Ca# + [19] , in that each bivalent ion has distinct effects on the conformation of the integrin. Mn# + appears to be highly effective at inducing the conformational changes associated with integrin activation, i.e. exposure of ligand-binding sites, as reported, for example, by enhanced exposure of the mAb JBS5, 16 and 12G10 epitopes that lie near to these sites. Mg# + can also induce these changes, but to a lesser extent than Mn# + . In contrast, although Ca# + appears to cause conformational changes to the α5 subunit that are similar to those caused by Mn# + or Mg# + , it suppresses the exposure of the 12G10 (activation) epitope on the β1 subunit. Hence, although occupancy of the integrin by Ca# + may allow the α subunit to achieve an active conformation, it appears to maintain the β subunit in an inactive conformation.
We used competitive ELISA experiments to test whether the domains of the α5 and β1 subunits that contain the epitopes of function-perturbing anti-α5 and anti-β1 mAbs are spatially overlapping. A similar approach has been used, for example, to map spatially overlapping biologically active domains in vitronectin [24] . Our results indicated that the ligand-binding domains on the α and β subunits are in close proximity to each other. However, an alternative explanation for the cross-inhibition we observed between the binding of anti-α5 and anti-β1 mAbs to α5β1 could be that these effects are due to allostery, i.e. the binding of one antibody causes a conformational change in the integrin that causes a second mAb to bind with lower affinity at a spatially distant site. For example, it might be expected that inhibitory mAbs could perturb the binding of stimulatory mAbs through allosteric effects on integrin conformation, and vice versa. Although we cannot rule out this explanation, we deem it unlikely for following reasons. (i) Inhibitory anti-α5 mAbs JBS5 and 16 perturbed the binding of both stimulatory (12G10) and inhibitory (mAb 13 and 4B4) anti-β1 mAbs (and vice versa). (ii) Only a subset of the function-altering mAbs showed the capacity to cross-inhibit (P1D6 and TS2\16 failed to cross-inhibit). (iii) The binding of mAbs JBS5 and 16 is perturbed by 12G10 but not by other stimulatory mAbs, such as N29, 9EG7 and 15\7, which recognize other regions of the β1 subunit [25] [26] [27] (A. P. Mould and A. N. Garratt, unpublished work). (iv) The degree of crossinhibition was greatest in the inactive (i.e. conformationally constrained) state of the integrin. All these observations cannot readily be explained if the cross inhibition is due to allosteric effects, but they can be accounted for by a spatial overlap between the JBS5\mAb 16 and mAb 13\12G10 clusters of epitopes. Spatial proximity between the second and third Nterminal repeats of the α subunit and the putative A-domain region of the β subunit is also implied by the cross-linking of an RGD-containing peptide to both these regions in αVβ3 [28] . More recently, evidence has been obtained that folding of the β-propeller domain formed by the N-terminal repeats of the αL subunit and the putative A-domain region of the β2 subunit is dependent on an association between these two modules [29, 30] . Point mutations in the putative A-domain region of the β2 and β3 subunits have also been shown to affect subunit-subunit interactions [31, 32] . Our findings for α5β1 suggest that loop regions on the upper surface of the α subunit β-propeller (in the second and third N-terminal repeats) and residues 207-218 of the β subunit putative A-domain may form part of an interface between these two modules.
Interestingly, we found that the epitope of P1D6, an mAb that blocks recognition of the synergy site but not the RGD site in fibronectin by α5β1, appears not to lie close to the epitopes of the function-altering anti-β1 mAbs, whereas the epitopes of JBS5 and 16, mAbs that do block recognition of the RGD sequence in fibronectin ( [15] , and A. P. Mould, unpublished work), are predicted to be close to those of function-altering anti-β1 mAbs. Hence, the epitopes of mAbs JBS5 and 16 may be close to the RGD-binding site (mainly on the β subunit), whereas the epitope of P1D6 appears to be relatively distant from this site but close to a site involved in recognition of the synergy sequence (mainly on the α subunit).
Our previous studies on the binding of fibronectin fragments to α5β1 [15] allowed us to propose that the β-propeller domain of the α5 subunit and the putative A-domain of the β1 subunit are arranged side by side in the ligand-occupied state of α5β1. Our current findings suggest that these two domains are partly overlapping in the inactive state. A model of integrin quaternary structure has been proposed recently [22] , based on the crystal structure of heterotrimeric G-proteins. In this model, the β subunit putative A-domain is proposed to lie on the top surface of the α subunit β-propeller, and to mask ligand-binding sites in the second and third repeats. In the active conformation of the integrin, the β subunit putative A-domain is released from its contacts with the propeller and exposes the ligand-binding sites in the second and third repeats. Our findings are consistent with this model, and we further speculate that amino acids 207-218 of the putative β1 A-domain may form part of a conformational switch, analogous to the switch II region of heterotrimeric Gprotein α subunits [33, 34] .
Finally, it should be pointed out that our findings do not exclude a possible direct role of cations in integrin-ligand recognition [5, 6, 35] . It is conceivable that bivalent ions could be required both for a proposed bridging interaction between integrin and ligand, and to induce conformational changes that expose ligand-binding sites. In the future it will be important to elucidate more fully the nature of these conformational changes, how subunit-subunit interactions are altered by bivalent-cation occupancy, and the precise location of the cation-binding sites involved in this regulation.
